Company profile
Cosmo Artificial Intelligence - Ai, Ltd.
Cosmo Artificial Intelligence - Ai, Ltd. has 6 AI-enabled medical devices on the FDA list. The first decision was on April 9, 2021 and the most recent on May 29, 2026 (GI Genius Module 300 (GGM300-US);ColonPRO US (CPRO403S-US)). Its most common review panel is Gastroenterology-Urology (6 devices).
6AI devices
2021First decision
2026Latest decision
1Specialties
Per year
2021202320242026
By specialty
Related guides
Timeline
- GI Genius Module 300 (GGM300-US);ColonPRO US (CPRO403S-US) · Gastroenterology-Urology · QNP
- GI Genius Module 100 (GGM100.US); GI Genius Module 200 (GGM200.US); ColonPRO 4.0 (CPRO40.US); GI Genius Module 300 (GGM300-US); ColonPRO 4.0 (CPRO40S-US) · Gastroenterology-Urology · QNP
- GI Genius Module 100 (GGM100.US); GI Genius Module 200 (GGM200.US); ColonPRO 4.0 (CPRO40.US) · Gastroenterology-Urology · QNP
- GI Genius System 100 and GI Genius System 200 · Gastroenterology-Urology · QNP
- GI Genius · Gastroenterology-Urology · QNP
- GI Genius · Gastroenterology-Urology · QNP